Bionovate Technologies Corp (BIIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 45.37 Thousand USD | 37.26% |
| 2019 | 33.05 Thousand USD | -41.54% |
| 2018 | 56.54 Thousand USD | -52.44% |
| 2017 | 118.87 Thousand USD | 34.11% |
| 2016 | 88.64 Thousand USD | 125.15% |
| 2015 | 39.36 Thousand USD | -19.47% |
| 2014 | 48.88 Thousand USD | -45.29% |
| 2013 | 89.35 Thousand USD | -1.07% |
| 2012 | 90.32 Thousand USD | 545.25% |
| 2011 | 13.99 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 6279.00 USD | 43.49% |
| 2020 Q4 | 4376.00 USD | -73.77% |
| 2020 Q2 | 20.68 Thousand USD | 471.18% |
| 2020 Q1 | 3622.00 USD | -39.07% |
| 2020 FY | 45.37 Thousand USD | 37.26% |
| 2020 Q3 | 16.68 Thousand USD | -19.35% |
| 2019 Q2 | 10.95 Thousand USD | -18.36% |
| 2019 Q4 | 5945.00 USD | 116.34% |
| 2019 FY | 33.05 Thousand USD | -41.54% |
| 2019 Q1 | 13.41 Thousand USD | -24.28% |
| 2019 Q3 | 2748.00 USD | -74.9% |
| 2018 Q2 | 18.33 Thousand USD | 21.43% |
| 2018 Q4 | 17.71 Thousand USD | 228.51% |
| 2018 FY | 56.54 Thousand USD | -52.44% |
| 2018 Q1 | 15.1 Thousand USD | -51.81% |
| 2018 Q3 | 5392.00 USD | -70.59% |
| 2017 Q2 | 42.32 Thousand USD | 22.18% |
| 2017 FY | 118.87 Thousand USD | 34.11% |
| 2017 Q4 | 31.33 Thousand USD | 196.42% |
| 2017 Q3 | 10.57 Thousand USD | -75.02% |
| 2017 Q1 | 34.64 Thousand USD | 377.29% |
| 2016 FY | 88.64 Thousand USD | 125.15% |
| 2016 Q1 | 4909.00 USD | -58.94% |
| 2016 Q4 | 7258.00 USD | -75.46% |
| 2016 Q2 | 52.44 Thousand USD | 968.32% |
| 2016 Q3 | 29.58 Thousand USD | -43.6% |
| 2015 FY | 39.36 Thousand USD | -19.47% |
| 2015 Q4 | 11.95 Thousand USD | 12.69% |
| 2015 Q1 | 9222.00 USD | -50.93% |
| 2015 Q3 | 10.6 Thousand USD | 39.91% |
| 2015 Q2 | 7583.00 USD | -17.77% |
| 2014 Q3 | 9028.00 USD | -11.53% |
| 2014 Q4 | 18.79 Thousand USD | 108.15% |
| 2014 FY | 48.88 Thousand USD | -45.29% |
| 2014 Q2 | 10.2 Thousand USD | -6.42% |
| 2014 Q1 | 10.9 Thousand USD | -62.23% |
| 2013 FY | 89.35 Thousand USD | -1.07% |
| 2013 Q2 | 26.43 Thousand USD | 57.04% |
| 2013 Q3 | 17.21 Thousand USD | -34.9% |
| 2013 Q1 | 16.83 Thousand USD | -67.29% |
| 2013 Q4 | 28.87 Thousand USD | 67.75% |
| 2012 Q2 | 5636.00 USD | 69.5% |
| 2012 Q4 | 51.47 Thousand USD | 125.82% |
| 2012 FY | 90.32 Thousand USD | 545.25% |
| 2012 Q1 | 3325.00 USD | 4.33% |
| 2012 Q3 | 22.79 Thousand USD | 304.42% |
| 2011 FY | 13.99 Thousand USD | 0.0% |
| 2011 Q4 | 3187.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | 740.67 Thousand USD | 100.0% |
| IR-Med Inc. | 4.89 Million USD | 100.0% |
| Polarean Imaging plc | 12.24 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 100.0% |
| Avitar, Inc. | 3.56 Million USD | 100.0% |
| AVITA Medical, Inc. | 80.77 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| Zecotek Photonics Inc. | 3.46 Million USD | 100.0% |
| QHSLab, Inc. | 961.65 Thousand USD | 100.0% |
| Wellstar International, Inc. | 1.79 Million USD | 100.0% |
| Össur hf. | 396.18 Million USD | 100.0% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 100.0% |
| Escalon Medical Corp. | 5.25 Million USD | 100.0% |
| Aurora Spine Corporation | 8.65 Million USD | 100.0% |
| BrainsWay Ltd. | 28.01 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 9.56 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 100.0% |
| Vivos Inc. | 2.78 Million USD | 100.0% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 2.27 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 100.0% |
| Nanomix Corporation | 8.36 Million USD | 100.0% |
| Theraclion SA | 7.43 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 1.29 Million USD | 100.0% |
| Positron Corporation | 1 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 100.0% |
| Lombard Medical, Inc. | 30.29 Million USD | 100.0% |
| ALR Technologies Inc. | 6.33 Million USD | 100.0% |
| Stratec SE | 46.32 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.27 Million USD | 100.0% |
| Heart Tronics, Inc. | 14.46 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 63.63 USD | 100.0% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 100.0% |
| Ingen Technologies, Inc. | 1.88 Million USD | 100.0% |
| Odyssey Group International, Inc. | -14.26 Million USD | 100.0% |
| United American Healthcare Corporation | 59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 100.0% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 100.0% |
| Urologix, Inc. | 10.09 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 100.0% |
| SS Innovations International, Inc. | 21.38 Million USD | 100.0% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 100.0% |
| Smith & Nephew plc | 3.46 Billion USD | 100.0% |
| NIOX Group Plc | 22.27 Million USD | 100.0% |
| Fuse Medical, Inc. | 10.35 Million USD | 100.0% |
| Broncus Holding Corporation | 38.15 Million USD | 100.0% |
| Brain Scientific Inc. | 9.66 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 100.0% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | 100.0% |